ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 630

Galectin-3-Binding Protein Is Highly Increased On Circulating Microparticles In SLE Patients and Co-Localizes With IgG In Glomerular Deposits In Human Lupus Nephritis

Christoffer T. Nielsen1,2, Ole Østergaard3, Ole Petter Rekvig4, Gunnar K. Sturfelt5, Søren Jacobsen6 and Niels H. H. Heegaard7, 1Department of Clinical Biochemistry, Immunology & Genetics, Statens Serum Institut, Copenhagen S, Denmark, 2Infectious Diseases and Rheumatology, University Hospital Rigshospitalet, Copenhagen, Denmark, 3Department of Clinical Biochemistry, Immunology & Genetics, Statens Serum Institute, Copenhagen S, Denmark, 4Department of Biochemistry and Medical Biology, University Hospital, Tromsø, Norway, 5Department of Rheumatology, University Hospital Lund, Lund, Sweden, 6Department of Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, 7Department of Clinical Biochemistry, Immunology & Genetics, Statens Serum Institut, Copenhagen, Denmark

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: autoantigens, galectin, lupus nephritis and microparticles, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: Mechanisms and Biomarkers

Session Type: Abstract Submissions (ACR)

Background/Purpose: The origin of autoantigens in glomerular immune complex (IC) deposits in lupus nephritis patients is unknown. They may derive from the circulation (microparticle (MP)-ICs or soluble ICs) or from apoptotic glomerular cells. Galectin-3-binding protein (G3BP) may be a specific marker of SLE cell-derived MPs. Here, we characterize G3BP-positive MPs in plasma from SLE patients compared to healthy controls (HCs), explore clinical correlates, and use G3BP to identify MP-components in IC deposits in kidney biopsies from patients with lupus nephritis. 

Methods: Plasma MPs were analyzed in 56 SLE patients and 36 healthy controls. MPs were enumerated by flow cytometry for G3BP exposure and annexin V (AnxV) binding. MP-quantitation of G3BP, IgG, and C1q were obtained by tandem mass spectrometry (LC-MS/MS). Co-localization of anti-G3BP antibodies with in vivo-bound IgG was examined in kidney biopsies from SLE patients with class IV (diffuse proliferative, n=2) and class IV (membranous, n=1) and in one control using co-localization immune electron microscopy.

Results: LC-MS/MS quantities of MP-G3BP, -IgG and -C1q were significantly increased in SLE patients (p<0.05 in all cases). Three different G3BP-positive MP-populations could be identified by flow cytometry. Two of these were significantly increased in SLE patients compared to HCs (p=0.008 and p=0.001, respectively). No significant clinical associations were observed. G3BP co-localized with in vivo-bound IgG in all three lupus nephritis biopsies while absent from control tissue. The G3BP was confined to the IC deposits and detected diffusely throughout the sections.  

Conclusion: G3BP overexpression is a key feature of SLE-MPs irrespective of clinical manifestations or disease activity. The distinct overlap of glomerular G3BP and IC deposits strongly suggests MPs to be an important source of autoantigens in lupus nephritis.


Disclosure:

C. T. Nielsen,
None;

O. Østergaard,
None;

O. P. Rekvig,
None;

G. K. Sturfelt,
None;

S. Jacobsen,
None;

N. H. H. Heegaard,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/galectin-3-binding-protein-is-highly-increased-on-circulating-microparticles-in-sle-patients-and-co-localizes-with-igg-in-glomerular-deposits-in-human-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology